The QualityStocks Daily Friday, July 5th, 2019

Today's Top 3 Investment Newsletters

Schaeffer's (OASM) +63.41%

QualityStocks (APPB) +46.67%

Penny Stock Titans (VEII) +32.14%

The QualityStocks Daily Stock List

Newrange Gold Corp. (NRGOF)

MicroSmallCap, Mining Stock Education, Proactive Investors, Investing News, GlobeNewswire, Metals News, Wallet Investors, Morningstar, Mining Capital, TheNewswire, StreetWise Reports, Investorx, Resource World, 4-Traders, Stockhouse, Junior Mining Network, Stockwatch, and The Prospector News reported earlier on Newrange Gold Corp. (NRGOF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Newrange Gold Corp. diversified into the U.S. in 2016 through acquiring the high-grade Pamlico gold project in the State of Nevada. A team of successful company builders and mine finders leads Newrange. With greater than 100 years of combined Nevada exploration experience this team has been involved in the discovery of 60+M oz gold and 200+ M ozs silver. Newrange Gold focuses on near to intermediate term production opportunities in favorable jurisdictions including Nevada, Colorado and Colombia.

The Company previously went by the name Colombian Mines Corporation. It changed its name to Newrange Gold Corp. in December of 2016. Incorporated in 2006, Newrange Gold is based in Vancouver, British Columbia.

The Pamlico Gold Project in Nevada is district-scale and nearly unexplored, with multi-million ounce potential in the legendary Walker Lane trend of Nevada. The Pamlico Project will see major exploration throughout this year. The Project is positioned 12 miles southeast of Hawthorne, Nevada, along US Highway 95.

The Pamlico Gold Project enjoys first-rate access and infrastructure, a mild, year-round operating climate and strong political support from Mineral County, one of the most pro-mining counties in the pro-mining State of Nevada. The Pamlico project encompasses the historic Pamlico group of mines, and also the nearby Good Hope, Gold Bar and Sunset mines.

In early June, Newrange Gold announced it negotiated a highly favorable, non-binding “Heads of Agreement” with private Australian company, Andean Mining Corporation Pty Ltd. for the sale of Newrange’s wholly-owned Colombian subsidiary, Corporacion Minera de Colombia (CMC) together with the El Dovio and Anori exploration projects, and exclusive of the Yarumalito gold porphyry project that Newrange will maintain ownership of for the time being. Subject to due diligence by Andean, Andean will pay Newrange Gold $1 million US in staged payments within nine months, together with certain other considerations.

This week, Newrange Gold provided an update on exploration activities for the balance of this year on the Pamlico Project in Nevada. Having recently completed a financing and being in the process of monetizing its Colombian assets, Newrange will be in a good position to further advance the project.

Underground surveying, mapping and channel sampling are continuing. The specific emphasis is on the Gold Bar Mine that lies between Good Hope and the Merritt Decline, where visible gold has been found in the historic dumps in front of the mine openings.

New underground workings have been discovered, adding to the estimated 8,000 meters of underground development. Moreover, the field crew is roughly 50 percent complete in their assessment of these areas. Greater than 1,000 samples have been taken to date. Results are being compiled.

Newrange Gold Corp. (NRGOF), closed Friday's trading session at $0.125777, off by 5.4912%, on 104,983 volume with 36 trades. The average volume for the last 3 months is 83,827 and the stock's 52-week low/high is $0.0414/$0.207300007.

chart

Sunniva, Inc. (SNNVF)

NetworkNewsWire, Midas Letter, Pot Stock News, StockAP, Micro Small Cap, New Cannabis Ventures, YCharts, Profit Confidential, Morningstar, Proactive Investors, Market Screener, TipRanks, Stockwatch, Barchart, GuruFocus, PR Newswire, GlobeNewswire, Nasdaq, Stockhouse, Seeking Alpha, and Market Watch reported earlier on Sunniva, Inc. (SNNVF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sunniva, Inc. is a North American provider of cannabis products and services. The Company, via its subsidiaries, is a vertically integrated cannabis business operating in the world's two largest cannabis markets – the State of California and Canada. Sunniva's Management and Board Of Directors have a proven record of accomplishment for creating significant shareholder value both in the healthcare and biotechnology industries. OTCQB-listed, Sunniva is relocating its head office to Carlsbad, California from Vancouver, British Columbia.

In Canada, the Company’s wholly owned subsidiary, Natural Health Services Ltd., operates medical cannabis clinics, which provide educational and clinical services to patients. In California, Sunniva is centered on creating sustainable premium cannabis brands supported by its large-scale, purpose-built cGMP designed greenhouse and extraction facilities.

Sunniva provides cannabis products free from pesticides. This positions the Company in California as a top provider of safe, high quality, reproducible products at scale. Through production from Phase One of its strategically positioned 325,000 square foot high technology greenhouse that is nearing completion and its fully operational Extraction Facility in California, Sunniva is launching Sunniva branded products in diverse product categories and price points. These include flower, pre-rolls, vape cartridges, as well as premium concentrates.

At the end of May, Sunniva announced the appointment of Mr. David Lyle as Chief Financial Officer (CFO), effective June 3, 2019, who will be based in California. Mr. Lyle earlier served as CFO at Maxwell Technologies, Inc. (MXWL), a worldwide leader in the development and manufacture of unique, cost-effective energy storage and power delivery solutions. Mr. Lyle takes over for Mr. David Negus, who transitions to supporting the Company in a consulting role beginning at the end of June 2019. As a result of Sunniva's stated plans to focus mainly on its California operations, the corporate functions will be relocated from Vancouver to Carlsbad.

Last month, Sunniva and CannaPharmaRx, Inc. (OTC Pink: CPMD) announced that they entered into a share purchase agreement dated June 11, 2019. Sunniva has agreed to sell Sunniva Medical, Inc. (SMI) to CannaPharmaRx in an all-cash transaction for CAD $20 million less certain outstanding liabilities in SMI. This includes the mortgage on the property. Net Proceeds Payable to Sunniva are expected to be roughly CAD $15.5 million.

Effectiveness of the agreement is subject to certain closing conditions including completion of a financial audit of SMI and receipt of sufficient financing by the Purchaser. SMI owns the Sunniva Canada Campus that includes construction assets for a planned 759,000 square foot greenhouse situated on an approximately 114-acre property in Okanagan Falls, British Columbia.

Additionally, in June, Sunniva announced additions to its California operations management team in Cathedral City in preparation for the start of cultivation operations at the Sunniva California Campus glasshouse. Mr. Eric Rosas has joined in the position of General Manager for the glasshouse and extraction facilities. Mr. Jose Calderon has been hired as the Head Grower for the glasshouse. Mr. James Boesiger will assume the position of Maintenance Manager of the glasshouse and extraction facilities.

Sunniva, Inc. (SNNVF), closed Friday's trading session at $1.9991, off by 1.0347%, on 50,783 volume with 81 trades. The average volume for the last 3 months is 89,765 and the stock's 52-week low/high is $1.86000001/$6.32999992.

chart

CCUR Holdings, Inc. (CCUR)

Stock Twits, Pitch Book, Tip Ranks, Zacks, MarketWatch, Last10k, Stocksholm, Seeking Alpha, Stockhouse, Insider Tracking, 4-Traders, YCharts, Value Walk, Vintage Value Investing, Simply Wall St, Market Screener, The Street, Stockwatch, InvestorsHub, and Equity Clock reported previously on CCUR Holdings, Inc. (CCUR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

CCUR Holdings, Inc., formerly known as Concurrent Computer Corporation, changed its name in January of 2018 following the sale of its former Real-Time business to Battery Ventures in May of 2017 and Content Delivery & Storage business in December of 2017. CCUR Holdings is now pursuing business opportunities to maximize the value of its assets through evaluation of additional operating businesses or assets for acquisition, continued development of its current real estate operations through its subsidiary Recur Holdings LLC, and continued development of its MCA business operations through its subsidiary LMCS. Eastbalished in 1966, CCUR Holdings is based in Duluth, Georgia and the Company lists on the OTC Markets’ OTCQB.

CCUR Holdings’ assets include its real estate operations (operated via subsidiary Recur Holdings), cash, securities held, receivables from the sale of its operating businesses held in escrow, taxes receivable, and tax assets attributable to its Net Operating Losses.

CCUR Holdings earlier announced that by way of its newly created subsidiary, LM Capital Solutions, LLC (LMCS), it closed on a Purchase Agreement to acquire the operating assets of LuxeMark Capital, LLC. LuxeMark operates through its syndication network to facilitate merchant cash advance (MCA) funding through connecting a network of MCA originators with syndicate participants who provide those originators with more capital by purchasing participation interests in funded MCAs. In addition, LuxeMark uses its expertise in the MCA industry to provide servicing and other administrative services to its syndicate network.

Recently, CCUR Holdings reported Net Income for Q3 of 2019 of $1,411,000, or $0.16 per share. This represents an improvement from the Net Loss of $1,093,000, or $0.11 a share for the year-ago comparable period. Revenue for the quarter almost tripled on a sequential basis to $1,074,000 with Merchant Cash Advance (MCA) income increasing to $825,000 and Interest Income on Loans increasing to $249,000. Other Interest, Dividend and Investment Income for the period totaled $1,557,000.

CCUR Holdings, Inc. (CCUR), closed Friday's trading session at $3.91, even for the day, on 32 volume. The average volume for the last 3 months is 5,219 and the stock's 52-week low/high is $3.00/$5.35500001.

chart

Elev8 Brands, Inc. (VATE)

MicroSmallCap, Pot Stock News, PennyStocks.News, Pot Network, Emerging Growth, Investors Hangout, PR Newswire, OTC Markets, Stockopedia, Stockwatch, Trading View, NIC Investors, and InvestorsHub reported previously on Elev8 Brands, Inc. (VATE), and today we report on the Company, here at the QualityStocks Daily Newsletter.

A holding company, Elev8 Brands, Inc. concentrates on the commercial development of hemp and cannabinoid-infused beverages. The Company also concentrates on a variety of CBD (cannabidiol) topicals and tinctures. Its corporate mission is to create the highest-quality, organic hemp products for consumers in search of a healthier, happier lifestyle. Elev8 Brands has its corporate office in Longwood, Florida.

The Company sources only the best organic hemp protein powders. These are those naturally full of powerhouse amino acids and Omegas-3, 6, and 9. It then infuses coffee and tea with an abundance of minerals, vitamins, antioxidants, and fiber. CBD-infused coffees and teas are Elev8 Brands’ specialty.

Hemp fiber can be turned into textiles. The plant itself is environmentally friendly. Hemp as a food, is highly nutritious, a powerful anti-inflammatory, an antioxidant, as well as a pain reliever. In addition, Hemp is considered a perfect, or complete protein. As such, it contains all 20 amino acids. This includes nine that the body can’t produce. Amino acids are the building blocks of protein; protein is the building block of muscle.

Last month, Elev8 Brands announced two new business relationships with highly sought-after companies MJ Distro and Spigel Distribution. Elev8 Hemp recently signed deals with MJ Distro and Spigel Distribution.

MJ Distro is 100 percent owned, operated, and staffed by U.S. Disabled Veterans who strongly believe in the health benefits offered by hemp and CBDs. Serving Central New York, MJ Distro is very excited to promote these beliefs and bring the benefits to their own communities. MJ Distro believes Elev8’s products will be quickly stocked alongside their other CBD offerings at all their retail customers’ locations.

Spigel Distribution is also known as “T.J. Distribution.” It has entered into an agreement with Elev8 Hemp to bring their CBD products to the greater Boston area. At present, their team covers the entire State of Massachusetts and Rhode Island, distributing products to more than 150 locations.

Furthermore, Elev8 Brands announced a new contract with Trident Distribution and reports increased year-over-year sales. Mr. Darrell Wordelmann, Co-Owner of Trident Distributors, said, “We at Trident Distributors, LLC are very particular on the items we bring in, especially being a boutique-style business. Literally from the first sip of the Lemon Iced Tea we knew this was going to be a drink that will hit the shelves fast. Trident is excited to be working with Elev8 and their future endeavors as we respect the vision they have for their company to expand and grow to the next level.”

Moreover, Elev8 Hemp, LLC. is reporting a significant 430 percent growth for combined Revenues of Elev8 Hemp and Zoe CBD for May 2019 versus May 2018. June was on track to exceed May’s sales.

Elev8 Brands, Inc. (VATE), closed Friday's trading session at $0.0441, up 0.227273%, on 902,373 volume with 70 trades. The average volume for the last 3 months is 3,710,319 and the stock's 52-week low/high is $0.0262/$0.073025003.

chart

Item 9 Labs Corp. (INLB)

Financial Buzz, Stockwatch, Investors Hangout, Trading View, Dividend Investor, GuruFocus, Equity Clock, Business Insider, InvestorsHub, Invest Tribune, CannabisMarketCap, Pot Stock News, Tip Ranks, Market Screener, Financial Content, Stockhouse, Wallet Investor, GlobeNewswire, and OTC Markets reported beforehand on Item 9 Labs Corp. (INLB), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Item 9 Labs Corp. is a leader in comfortable cannabis health solutions for the modern consumer. The Company is bringing best of industry practices to markets across the country by way of cultivation and production, distinctive retail environments, licensing services, and diverse product suites. It caters to different medical cannabis demographics. Item 9 Labs is headquartered in Phoenix, Arizona. It also has medical cannabis operations in manifold U.S. markets.

The Company will be managing cultivation, processing, distribution, and dispensary operations in up to ten U.S. markets by the end of 2019. Current facilities include distribution and processing operations - Strive Wellness of Ohio and Strive Wellness of Nevada, and a dispensary - Strive Life North Dakota.

The Company’s asset portfolio includes Dispensary Permits, Dispensary Templates, as well as the aforementioned Strive Life. Dispensary Permits is its consulting firm. It specializes in strategic license application and compliance. Dispensary Templates, a subdivision of the firm, is a technology platform with an extensive digital library of licensing and business planning resources.

Strive Life is a turnkey dispensary model for the retail sector. It improves the patient experience with consistent and premier service, high-end design, and also precision-tested products. Currently, Strive Life is undergoing implementation in the States of Arizona and North Dakota.

Item 9 Labs has also created complementary brands - Item 9 Labs and Strive Wellness - to channel consumer diversity. Propriety delivery platforms include the Apollo Vape and Pod system, and a pioneering intra-nasal device. Item 9 Labs has received numerous tributes for its medical-grade flower and concentrates.

Item 9 Labs announced this past April that it launched construction of Strive Wellness of Nevada. This is a medical cannabis cultivation and processing facility. It has distribution rights in Pahrump, Nevada. In June of 2018, Item 9 Labs became an operating partner of Strive Wellness of Nevada. The new cultivation and production space encompasses 20,000 square-feet. This doubles the overall square-footage of Item 9 Labs’ existing aggregate facilities.

Medical marijuana dispensary Strive Life Grand Forks, a partner following the Company’s Strive Life business model and brand, officially opened on Wednesday, May 22, 2019, at 1809 13th Avenue North, in Grand Forks, North Dakota. Strive Life Grand Forks implements medical marijuana dispensary best practices from across the U.S. and internationally. The dispensary model offered by Item 9 Labs features thoughtfully designed environments for an elevated patient experience.

Last month, Item 9 Labs announced its expanded Arizona cultivation and manufacturing facility received State approval to operate. The custom 10,000 square-foot construction passed inspections on June 4, 2019, and commenced production a week later.

Item 9 Labs Corp. (INLB), closed Friday's trading session at $4.25, off by 5.5556%, on 2,157 volume with 6 trades. The average volume for the last 3 months is 4,633 and the stock's 52-week low/high is $1.50/$8.39999961.

chart

MobileSmith, Inc. (MOST)

Zacks, Wallmine, GuruFocus, Business Insider, Capital Cube, Corporate Information, Stockopedia, Stockwatch, Proactive Investors, YCharts, MarketWatch, Simply Wall St, Market Screener, Marketbeat, Wallet Investor, Last10k, InvestorsHub, Trading View, Market Exclusive, 4-Traders, Dividend Investor, and Stockhouse reported beforehand on MobileSmith, Inc. (MOST), and today we report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, MobileSmith, Inc. is a leader in the digital health and mobile development sector. The Company provides operational improvement member-facing mobile application (app) services to the healthcare industry in the United States. It helps its clients improve health outcomes, patient satisfaction and grow profit margins utilizing its toolbox of proven mobile app technologies. MobileSmith is headquartered in Raleigh, North Carolina.

MobileSmith is changing healthcare one app at a time through targeting the evident inefficiencies in the U.S. healthcare delivery model. More than 60 healthcare systems and organizations are partnering with MobileSmith Health to deliver a new healthcare experience and embrace the impact of technology as an agent of change. In essence, the Company is helping its clients meet their healthcare consumers where they are, on their mobile devices, to expand the reach of providers to modify behavior with apps that remind, educate, track, and engage the patients that use them.

MobileSmith is concentrating on select patient segments that struggle with areas such as medication adherence, discharge instruction compliance, and health literacy, and provide new inventive digital patient experiences including indoor navigation and clinic “check-ins” that directly improve critical patient satisfaction.

Through the use of MobileSmith Health Blueprints, hospitals and other healthcare organizations can customize their apps based on specific feature sets, workflow, branding, protocol, procedure and service line. This is while launching in as little as 90 days.

The Company’s latest Blueprints 3.0 offerings provide expanded mobile capabilities across MobileSmith’s primary applications: In-Network Apps, Perioperative Apps, and Patient Acquisition apps. Additional Blueprint 3.0 features include key mobile-specific functionality such as self-triage, remote check-in, wayfinding, as well as EMR interoperability.

MobileSmith Health announced in May the launch of Perioperative Blueprints 4.0. The expanded app Blueprints include new functionality that tailors the patient experience pre- and post-op with the introduction of “Peri,” which offers AI-based (Artificial Intelligence) interactions that elevates patient literacy with conversational interfaces, video, and images. EMR integration and new adherence tracking dashboards allow providers to readily assess risk factors for complications, cancellations, or readmissions.

Recently, MobileSmith Health announced important customer application launches and acquisitions for the first half of 2019. One example is: Tift Regional Medical Center released an update to their app – Tift Regional Medical Center. The update includes MobileSmith Health’s first turn-by-turn directions integration with Eyedog indoor navigation. Another example is: St. Francis Hospital launched a new pregnancy app – New Beginnings – based on the MobileSmith Health Blueprints.

Mr. Randy Tomlin, MobileSmith Chief Executive Officer and Chairman of the Board, said, “In addition to these customer wins and product enhancements, we’ve also realigned our apps along two main care pathways—Navigate and Encounter. Navigate is a wayfinding app designed to improve the patient experience with a personalized view of care options, while Encounter offers instructions pre- and post-procedure that are customized based on the service and the provider. We’re confident these new app advancements will help contribute to another year of record-breaking growth for our company.”

MobileSmith, Inc. (MOST), closed Friday's trading session at $1.85, even for the day, on 15,545 volume. The average volume for the last 3 months is 448 and the stock's 52-week low/high is $0.75/$2.50999999.

chart

Spark Infrastructure Group (SFDPF)

Street Insider, Marketbeat, Wallet Investor, MarketWatch, Dividend Investor, Stockhouse, Seeking Alpha, YCharts, GuruFocus, and 4-Traders reported on Spark Infrastructure Group (SFDPF), and we also highlight the Company, here at the QualityStocks Daily Newsletter. 

Spark Infrastructure Group is an investment manager based in Sydney, Australia. The Company invests in the regulated utility infrastructure market. It invests in quality regulated utility infrastructure with an emphasis on Australian electricity networks. The Company has a long history of owning and investing in essential service infrastructure.

Its networks deliver safe and reliable electricity to greater than five million Australian homes and businesses. The Company concentrates on assets that offer relatively low risk and stable cashflows, facilitate the payment of relatively predictable distributions to investors, and offer the potential for long term capital growth. Spark Infrastructure lists on the OTC Markets.

Fundamentally, Spark Infrastructure Group is a specialist infrastructure fund. The Company comprises Spark Infrastructure Trust and its consolidated entities. The Spark Infrastructure Trust is a unit trust. It is a registered managed investment scheme. Spark Infrastructure RE Limited is the responsible entity of the Spark Infrastructure Trust.

Spark Infrastructure Group invests in regulated and unregulated utility infrastructure. This includes electricity and gas distribution and transmission and water and sewerage assets. Australia is the chief investment region for consideration.

Spark Infrastructure’s present investment portfolio consists of a 49 percent interest in electricity distribution businesses CitiPower and Powercor, together known as Victoria Power Networks, in Victoria. Its investment portfolio also consists of a 49 percent interest in electricity distribution business SA Power Networks in South Australia; and a 15.01 percent interest in electricity transmission business TransGrid in New South Wales.

A leader in essential service infrastructure, Spark has interests in $17.1 billion of energy network assets in total and a workforce of more than 5,300 employees. The Company delivers energy to over 5.6 million customers across three states.

It also transports electricity across the NEM between New South Wales and Queensland, Victoria and the Australian Capital Territory. Spark Infrastructure Group is a major investor in Australian Energy Network Service Providers regulated by the Australian Energy Regulator (AER).

Spark Infrastructure Group (SFDPF), closed Friday's trading session at $1.742, even for the day, on 2,300 volume. The average volume for the last 3 months is 649 and the stock's 52-week low/high is $1.54999995/$1.77999997.

chart

Thin Film Electronics ASA (TFECF)

Speculating Stocks, Dividend Investor, Wallet Investor, Penny Stock Millionaire, Penny Stock Tweets, Stockhouse, TradingView, OTC Markets, InvestorsHub, The Street and 4-Traders reported earlier on Thin Film Electronics ASA (TFECF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Thin Film Electronics ASA provides near field communication (NFC) mobile marketing and smart-packaging solutions by printed electronics technology. It provides end-to-end mobile marketing solutions that feature hardware, label/packaging integration services, and a robust cloud-based software platform.

OTCQX-listed, Thin Film Electronics is based in Oslo, Norway. Additionally, the Company has offices in Silicon Valley, Sweden, San Francisco, London, and Shanghai.

Thin Film’s vision is to make everyday items ‘just smart enough’, thus, effectively extending the traditional boundaries of the IoT to create the Internet of Everything. The Company has 270 patents and patents-pending.

Thin Film’s products include NFC Solutions. NFC involves hardware and software designed with volume production in mind. NFC Solutions is built on highly scalable printed electronics technology. NFC features OpenSense™ Technology - Dual-ID tag with sealed/opened sensor. In addition, it features SpeedTap™ Technology - Single-ID tag.

Moreover, Thin Film’s products include EAS Tags. These are for retailers to strengthen their retail loss-prevention programs with next-generation anti-theft tags. The Company’s 8.2MHz tags are compatible with globally installed infrastructure. Integrated EAS maximizes product availability and minimizes loss. EAS Tags also reduce overhead associated with hard tag application and removal.

This past November, Thin Film announced it received the IDTechEx Technical Development in Manfacturing award in recognition of its pioneering roll-to-roll printed electronics fab in San Jose, California. The IDTechEx Awards were presented as part of the Printed Electronics USA 2018 conference. They recognize company development and success in the field of printed electronics.

The Technical Development in Manufacturing award recognizes the most significant development of a manufacturing device, process, or production plant in the industry over the last 24 months. Award recipients must demonstrate the optimization of a lab-scale or mass-scale production process through improving productivity, quality, reliability, uniformity, or scale.

Thin Film’s San Jose facility features a 22,000 sq-ft printed electronics factory, which is the world’s first production roll-to-roll (R2R) printed electronics line using stainless steel substrates. The design of the fab is for an annual production capacity of up to seven billion units. It is optimized to enable production of low-cost, mechanically strong devices enabling high-volume applications. This includes NFC (near field communication) for mobile marketing, authentication, as well as supply chain services.

Thin Film Electronics ASA (TFECF), closed Friday's trading session at $0.015, up 29.3103%, on 110,000 volume with 5 trades. The average volume for the last 3 months is 42,833 and the stock's 52-week low/high is $0.011199999/$0.264999985.

chart

Applied BioSciences Corp. (APPB)

Stockhouse, MarketWatch, InvestorsHub, OTC Markets, Penny Stock Hub, Morningstar, Daily Marijuana Observer, Simply Wall St, Canadian Insider, GuruFocus, TradingView, Investors Hangout, Stockopedia, The Stock Market Watch, and Dividend Investor reported earlier on Applied BioSciences Corp. (APPB), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Applied BioSciences Corp. is a diversified cannabinoid therapeutics enterprise. The Company focuses on the medical, bioceutical and pet health industries. It was formerly known as Stony Hill Corp. Applied BioSciences’ emphasis is on select investment, branding, real estate, and partnership opportunities in the recreational, health and wellness, nutraceuticals and media industries. OTCQB-listed, Applied BioSciences is based in Beverly Hills, California.

The Company uses organic ingredients and formulations created to target common ailments in the health and wellness industry for anyone who is open to trying hemp derived products. These products use industrial hemp as an input to produce high quality CBD for an assortment of health and wellness products.

Applied Biosciences’ products include Remedi CBD and TherPet. Remedi CBD is a line of premium hemp-derived CBD products. These products include topicals, gummies, and more. The Company has expanded its product line and launched a hemp-derived CBD product line under the Remedi CBD brand. Furthermore, Applied BioSciences has began sales of its hemp-derived CBD products on LeafLink's industry-leading B2B (Business-to-Business) e-commerce platform.

Applied BioSciences’ wholly-owned animal health subsidiary is TherPet. The Company has entered the equine health market with the launch of a new full-spectrum hemp-derived cannabidiol (CBD) supplement formulated specifically for a horse's health and wellness. TherPet's Equine Care CBD line is a natural supplement.

Earlier this month, Applied Biosciences announced that it acquired a majority stake in Trace Analytics, Inc. Trace is a foremost testing and analytics company. The team has greater than 65 years of experience in the testing and analytics space. It also has a full-time staff of nine employees including, two Ph.D. analytical chemists and five other scientists. Applied Biosciences’ intention is to position Trace Analytics as the leading provider of testing solutions for compliance requirements and consumer safety.

Last week, Applied BioSciences announced that Dr. Xiang-Qun (Sean) Xie joined its Scientific Advisory Board. Dr. Xie has more than 30 years of experience in the fields of Genomics, Cancer Research. He also has has numerous patents that have been licensed to Biotechnology and Pharmaceutical companies.

Applied BioSciences Corp. (APPB), closed Friday's trading session at $0.88004, up 46.6733%, on 6,203 volume with 11 trades. The average volume for the last 3 months is 1,659 and the stock's 52-week low/high is $0.580500006/$2.95000004.

chart

First Foods Group, Inc. (FIFG)

Stockwolf, Stockwatch, Wall-St, OTC Markets, Real Investment Advice, Investors Hangout, The Street, Market Screener, TradingView, Stockhouse, Penny Stock Hub, Euro Investor, YCharts, and MarketWatch reported on First Foods Group, Inc. (FIFG),  and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

First Foods Group, Inc. has growing interests in the food and food service industry. The Company provides management services and financing options for new foodservice brands and menu concepts. Moreover, it is growing its new concepts through proprietary development and through mergers, acquisitions, and licensing arrangements. The Company formerly went by the name Litera Group, Inc. It changed its name to First Foods Group, Inc. in February 2017. First Foods Group has its head office in Las Vegas, Nevada.

First Foods Funding invests in short-term merchant cash advances that have been producing immediate high rates of return on capital. This Division continues to realize fast growth through the reinvestment of its profits while attracting substantial new funds from outside investors.

First Foods earlier signed cannabis business expert Mr. Robert Hunt, Esq. to identify opportunities in the legal cannabis industry where the Company’s management, expertise, and relationships could have considerable effect. Mr. Hunt is one of the distinguished consultants in the legalized marijuana industry. He has been instrumental in many of the best known and most successful cannabis businesses in operation today.

First Foods Group entered into a binding term sheet in April 2017 with globally renowned chocolatier and entrepreneur Mr. Oded Brenner. This is to fully develop Mr. Brenner’s new chocolate-based retail concept. The venture is jointly owned by First Foods Group and Mr. Brenner. Initial plans are to launch two flagship stores in New York, New York, and to immediately take advantage of numerous multi-unit global franchising opportunities. 

Holy Cacao is marketing premium chocolate products created and packaged by Holy Cacao consultant, Mr. Oded Brenner, founder of "Max Brenner, Chocolate by the Bald Man," for the legal cannabis sector. Mr. Brenner has incorporated an exotic mix of champagnes, sherries, and select cannabis strains into his chocolate formulas.

First Foods Group registered its Holy Cacao® subsidiary with the State of Nevada on August 31, 2017. The Company stated that Holy Cacao will soon be licensed as a THC product in the legal marijuana states.

First Foods Group recently reported GAAP Revenue of $85,510 for the second fiscal quarter of 2018. This represents an increase of 42 percent over the GAAP Revenue of $60,295 reported for the first fiscal quarter of 2018. The Company’s financial results are supporting the expansion of its Holy Cacao subsidiary. This subsidiary is finalizing negotiations to produce high-end chocolate, which will be sold and distributed to the edibles market using First Foods’ trademarked brand and packaging.

First Foods Group, Inc. (FIFG), closed Friday's trading session at $0.37, up 27.5862%, on 71,683 volume with 24 trades. The average volume for the last 3 months is 7,105 and the stock's 52-week low/high is $0.0401/$0.419999986.

chart

Vilacto Bio,  Inc. (VIBI)

OTC Markets and The Street reported on Vilacto Bio,  Inc. (VIBI),  and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Vilacto Bio,  Inc.  is a biotechnology company listed on the OTCQB. It has developed the now fully patented Lactoactive® (Lactoactive molecule). In numerous studies, Lactoactive® has demonstrated above average effect treating conditions such as inflammatory diseases, diabetes, psoriasis, skin aging, and skin issues in different levels. At present the Company’s products are available on the market as Vilact®.

Founded in 2013, Vilacto Bio is headquartered in New York, New York. The Company previously went by the name Zlato, Inc. It changed its name to Vilacto Bio, Inc. on April 4, 2017. The Company’s European Headquarters are in Næstved, Denmark. Its Research and Development (R&D) operations are in Lithuania.

Vilacto Bio’s goal is to be the leading biotechnology company centered on commercializing unique pharmaceutical cosmeceutical products formulated or reformulated with Lactoactive® as nanoparticle according to its patented properties.  The Company’s aim is to further develop its Lactoactive® molecule for increasing the quality of its retail and medical skin cream products, as well as licensing out its Lactoactive® molecule for the pharmaceutical industry.

  Lactoactive® is highly refined colostrum, developed to provide first-rate results for people needing healing or relief from a range of skin issues. Lactoactive® is a refined processing of colostrum combined with hyaluronic acid. Proteins in Vilact® survive longer without being degraded by enzymes. This enables them to work longer in the skin. 

Vilacto Bio has its Vilact Cuticle cream product, developed in cooperation with Danish podiatrists. Lactoactive, the ingredient molecule in Vilact Cuticle cream, works to help with skin challenges. Danish podiatrists have demonstrated its use with faster patient recovery.

This past January, Vilacto Bio announced that it started development of the Vilacto Bio Skincare Knowledge Center. This is an online resource that will gather skincare knowledge, science, insights and tips from scientists, dermatologists, podiatrists and other specialists around the world.

The tips and guides presented in the Vilacto Bio Knowledge Center will be shared with industry magazines internationally, and also with Vilacto customers. The expectation is that the Vilacto Bio Knowledge Center will enhance dialogue among specialists and consumers, improve outcomes, and drive higher traffic to Vilacto Bio’s commercial web portal.

Vilacto Bio,  Inc. (VIBI), closed Friday's trading session at $0.0002, even for the day, on 21,654,085 volume with 21 trades. The average volume for the last 3 months is 76,567,437 and the stock's 52-week low/high is $0.000199999/$0.694000005.

chart

Prism Technologies Group, Inc. (PRZM)

Zacks, Wall Street Journal, TradingView, MarketWatch, and InvestorsHub reported on Prism Technologies Group, Inc. (PRZM), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Prism Technologies Group, Inc. is an intellectual property (IP) licensing and technology research & development  (R&D)  company. The Company, by way of its wholly-owned subsidiaries, owns a patent portfolio consisting of nine patent families incorporating 61 issued and six pending patents in the Computer & Network Security, Semiconductors, and Medical Technology arena.

  Established in 1995, Prism Technologies Group is the parent company of Prism Technologies, LLC, which is a Nebraska Limited Liability Company (LLC) based in Omaha, Nebraska. Prism Technologies Group has its corporate office in Folsom, California.

The Company previously went by the name Internet Patents Corporation. It changed its name to Prism Technologies Group, Inc. in September of 2015. The Company lists on the OTC Markets Group’s OTCQB.

  Prism Technologies Group licenses and enforces a portfolio of patents relating to its technologies. It continues to develop and patent new technologies.

The Company’s dedication is to continuing R&D efforts in a number of fields. Its mission is to continue to develop and invent new technologies in computer and network security, wearable computing, transaction processing,  and healthcare to speed up time to market opportunities for its clients.

Prism Technologies Group’s Executive Team includes Mr. Hussein A. Enan - Chairman, Chief Executive Officer; and Mr. Greg Duman - President, Prism Technologies, LLC and member of Prism Group's Board of Directors. Mr. Duman chairs the Audit Committee.

Prism Technologies Group announced in October of 2017 that it entered into an Asset Purchase Agreement with Amorphous Technologies International (ATI). ATI is a leader in the development of innovative amorphous alloy solutions based on proprietary materials technology. Its solutions deliver value through removing the limits of existing materials technology, which result in high costs throughout the lifecycle of a product.

The Agreement is to acquire certain intellectual property (IP) assets related to unique uses for amorphous metals.  After the close of the transaction, Prism will commercialize the acquired IP assets to create new amorphous metal technology offerings for the consumer electronics, automotive, industrial, and other business sectors.

Prism Technologies Group, Inc. (PRZM), closed Friday's trading session at $0.0305, up 14.0827%, on 66,358 volume with 8 trades. The average volume for the last 3 months is 11,231 and the stock's 52-week low/high is $0.0151/$0.200000002.

chart

Cell Source, Inc. (CLCS)

InvestorsHub and OTC Markets reported on Cell Source, Inc. (CLCS), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter. 

Cell Source, Inc. is a Biotechnology Company listed on the OTC Markets Group’s OTCQB. The Company concentrates on developing cell therapy treatments established on immunotherapy and regenerative medicine. Its principal product is the Veto-Cell immune system management technology. Cell Source has its headquarters in New York, New York.

Cell Source’s Veto-Cell immune system management technology is an immune tolerance biotechnology. It enables the selective blocking of immune responses. The Company’s Veto-Cell technology is utilized in varied applications. These include bone marrow transplantation, veto-cell in transplantation, anti-cancer, and also non-malignant diseases. 

The patented Veto-Cell technology addresses one of the most fundamental challenges in human immunology. This challenge is: how to tune immune response so that it tolerates specific “desirable” foreign cells while continuing to attack all other potential threats. 

Veto cells disable the attack of the immune system on the bone marrow transplantation (BMT) only, without other side effects. The Veto cells act as “decoys” that attract, and then kill, the T-cell clones directed at the transplant.

The Veto cells continue “on guard” in the body for lengthy periods of time to further limit rejection. Therefore, the transplantation is accepted by the body without compromising the rest of the immune system. 

The principal goal in developing Veto Cells is to have a meaningful and potentially widespread  impact on the field of bone marrow and major organ transplantation. In addition, Veto Cells can be combined with other cell therapy treatments to improve their effectiveness. In preclinical studies, Veto Cells have been shown to increase efficacy and persistence of genetically modified cells. 

Along with its Veto Cells technology, Cell Source has its Megadose Drug Combination technology. The method of action includes stem cells overcoming rejection by outnumbering immune rejecting cells, and drugs reduce the need for immune suppression.

The Company has a substantial Intellectual Property (IP) Portfolio, exclusively licensed to it from the Weizmann Institute of Science by way of Yeda Research and Development Company Ltd. covering Dr. Yair Reisner’s technologies.

Dr. Yair Reisner is former Chairman of the Department of Immunology of Israel’s Weizmann Institute of Science. He pioneered “mismatched” BMT (partial versus full donor/recipient match) with his patented “Megadose” cell therapy treatment.

In essence, Cell Source’s corporate  mission is to transform the fields of transplantation, cancer treatment, and reversal of vital organ disease, using its pioneering immune tolerance and organ regeneration technologies.

Cell Source, Inc. (CLCS), closed Friday's trading session at $0.818, up 43.2574%, on 1,068 volume with 2 trades. The average volume for the last 3 months is 2,890 and the stock's 52-week low/high is $0.260100007/$1.48000001.

chart

China ShouGuan Investment Holding Group Corporation (CHSO)

OTC Markets, MarketWatch, InvestorsHub, Morningstar, GuruFocus, and StreetInsider reported on China ShouGuan Investment Holding Group Corporation (CHSO), and today we report on the Company, here at the QualityStocks Daily Newsletter.

China ShouGuan Investment Holding Group Corporation, with equity investment as its core, and operational entities as its foundation, is a large-scale integrated Investment holding Group. The OTCQB-listed Company has expanded its business layout that covers its investment bank business, the new energy industry, the environmental protection and energy-saving industry, the mining industry, the health industry, and also the hi-tech industry and more.

Incorporated in 2010, China ShouGuan Investment Holding Group Corporation is based in Shenzhen, China.

Regarding mining, China ShouGuan is a gold mining exploration, development, and advisory Company in the gold rich zones of Shandong and HeiLongJiang Provinces in the People’s Republic of China (PRC). The Company’s emphasis is acquiring or leasing under-performing mines in major mineral zones. It then finances their expanded exploration and production utilizing industry leading technologies. 

China ShouGuan’s projects include the Dayuan Gold Mine, which covers an area of 0.3475 square kilometers in Longkou city of Shandong; and the mine in the Daxinganling area in Heilongjiang Province in the northeastern part of China. 

China ShouGuan also provides mining technical advisory services. Moreover, the Company provides consulting services in the areas of geological analysis and mine exploration. The range of its mining business encompasses exploration, mining, beneficiation and technical consultation. Its principal business is gold mining, with geological prospecting and technical consultation as supplementary services. 

China ShouGuan Investment Holding Group is diversifying its business. The Company has its Pro-Environment; Eco-Agriculture; Health, and Investment initiatives. Pertaining to Pro-Environment, it entered into the environmental protection field through beginning with sewage sludge treatment and disposal. Relying on its ion fractionation sewage sludge treatment technology, the Company provides integral services for sewage sludge treatment projects. 

Regarding Eco-Agriculture, the agricultural company affiliated to Shouguan Group is one of the first companies to introduce and plant, and also work on product research of the Melaleuca tree in China. Concerning Health, China Shouguan’s commitment is to the development of the health industry, along with setting up funding and concentrating on the development of life sciences, health products, and investing in the health industry. Additionally, the Investment business line of China Shouguan covers industrial investment, financial investment, private equity fund management, investment banking services, and more. 

China ShouGuan Investment Holding Group Corporation (CHSO), closed Friday's trading session at $0.011292, up 11.802%, on 43,600 volume with 12 trades. The average volume for the last 3 months is 339 and the stock's 52-week low/high is $0.004999999/$0.029999999.

chart

The QualityStocks Company Corner

MustGrow Biologics Corp.

The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp..

MustGrow Biologics Corp. is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.

Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients (http://nnw.fm/Qkz21). For the past 50 years, nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical formulations.

MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://nnw.fm/3HGuT), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.

MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.

MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.

Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:

  • 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
  • 55 percent tomato crop yield increase
  • 95 percent control of Pythium root rot in lettuce fields
  • 70 percent reduction in Verticillium root severity in cucumbers
  • Market Opportunity

Market Opportunity??

MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers.?MustGrow’s?potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.?

Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated?$9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.??

MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.

Management Team

President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries.? Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.

Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.

COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.

Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis?(TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.

Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.

CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

San Mateo, California-based Plus Products (CSE: PLUS) (OTCQB: PLPRF) has emerged as a market leader in its home state since its introduction in 2015, quickly becoming the No. 1 best-selling, cannabis-infused edibles brand in California (http://nnw.fm/HcHs2). To view the full article, visit: http://nnw.fm/F65nJ.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Friday's trading session at $2.60, off by 0.383142%, on 32,235 volume with 67 trades. The average volume for the last 3 months is 74,300 and the stock's 52-week low/high is $2.51999998/$6.00810003.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, recently entered a supply agreement with Alberta Gaming, Liquor and Cannabis (“AGLC”) (http://nnw.fm/P0Eyw). To view the full article, visit: http://nnw.fm/M8oMy.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed Friday's trading session at $2.56, up 6.8894%, on 422,160 volume with 732 trades. The average volume for the last 3 months is 611,332 and the stock's 52-week low/high is $1.60699999/$7.89379978.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com Inc. (OTCQB: CIIX) was featured today in the 420 with CNW by CannabisNewsWire. Colorado Gov. Jared Polis (D) launched an online tool on Monday that will enable members of the public to keep track of what the state government is doing to attain its goals, which include taking the marijuana industry to greater heights.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Friday's trading session at $0.41, up 2.3465%, on 7,992 volume with 12 trades. The average volume for the last 3 months is 46,991 and the stock's 52-week low/high is $0.365000009/$1.25.

Recent News

chart

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)

The QualityStocks Daily Newsletter would like to spotlight Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF).

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) was featured today in the 420 with CNW by CannabisNewsWire. The agriculture department will do a lot to facilitate the attainment of the goals on hemp. A three-year development plan for this sector shows that the governor wants to see the indoor production of hemp increase to 10 million square feet from the current 7.67 million square feet. The plan also states that outdoor cultivation should increase to more than 60,000 square feet from the current 21,000 square feet.

Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF), an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements' expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.

Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company.

  • Investment and funding for rapid growth
  • Vertical integration solutions
  • Construction, design and/or optimization of indoor or outdoor cultivation facilities
  • Reputation management & influencer outreach
  • Branding and Packaging
  • Social Media and Media outreach

With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.

Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.

Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.

Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company "maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S."

Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree's working capital.

Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).

Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.

Chemistree Technology Inc. (CHMJF), closed Friday's trading session at $0.28, up 0.358423%, on 13,120 volume with 18 trades. The average volume for the last 3 months is 116,158 and the stock's 52-week low/high is $0.206484004/$0.605000019.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (GRYN) was featured today in a report by NetworkNewsWire. California is making progress in terms of enabling widespread commercial and industrial hemp cultivation. New industrial hemp regulations in the state establish registration procedures for growers and have already gone into effect (http://nnw.fm/2UlCn). As per California law, industrial hemp growers are required to register with their local County Agricultural Commissioner’s Office before initiating cultivation.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed Friday's trading session at $1.3875, off by 7.50%, on 58,699 volume with 35 trades. The average volume for the last 3 months is 16,827 and the stock's 52-week low/high is $0.100100003/$1.80999994.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTC:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces that in has retained Streetwise Investors Club Inc. dba the Richmond Club to provide media services to the Company for an initial six-month term, which is automatically renewed unless terminated. The Richmond Club is a Toronto-based company that showcases companies they believe are undervalued and have high growth potential.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Friday's trading session at $0.8602, off by 1.1264%, on 52,607 volume with 42 trades. The average volume for the last 3 months is 84,370 and the stock's 52-week low/high is $0.75/$2.24.

Recent News

chart

Geyser Brands Inc. (TSX.V: GYSR)

The QualityStocks Daily Newsletter would like to spotlight Geyser Brands Inc. (TSX.V: GYSR).

Vancouver, British Columbia-based consumer health care company Geyser Brands (TSX.V: GYSR) is engaged in creating first-class, cannabis-focused health care products and brands. To view the full article, visit: http://nnw.fm/Cj5zF.

Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.

NanoFusion Technology

The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.

Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.

Operations

Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.

Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.

Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.

Growing Portfolio

Among the brand formulations in Geyser Brand's portfolio are:

  • Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
  • Prohibition Cold Brew Mocha designed with water soluble hemp molecules
  • Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
  • Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control

Management Team

Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.

CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.

Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.

Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.

Geyser Brands Inc. (TSX.V: GYSR), closed Friday's trading session at $0.56, off by 3.4483%, on 4,500 volume with 3 trades. The average volume for the last 3 months is 9,051 and the stock's 52-week low/high is $0.50999999/$0.850000023.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Described as a leading single-source provider of end-to-end, next-gen telecommunications networks, Spectrum Global Solutions Inc. (OTCQB: SGSI) services reach across the United States, Canada, Puerto Rico, Guam and the Caribbean. The company’s end-to end offerings include bundled products of full-service engineering, construction, installation, maintenance and professional services. To date, SGSI has completed more than 150,000 projects on wireless, Distributed Antenna System (DAS), wireline and fiber networks.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed Friday's trading session at $0.056672, off by 16.6588%, on 147,600 volume with 18 trades. The average volume for the last 3 months is 105,814 and the stock's 52-week low/high is $0.045000001/$2.5999999.

Recent News

chart

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (OTCQB: NUGS).

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (OTCQB: NUGS), closed Friday's trading session at $0.5699, off by 1.7075%, on 17,091 volume with 37 trades. The average volume for the last 3 months is 83,204 and the stock's 52-week low/high is $0.550000011/$5.94000005.

Recent News

chart

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed Friday's trading session at $0.12025, off by 8.2061%, on 84,350 volume with 16 trades. The average volume for the last 3 months is 49,689 and the stock's 52-week low/high is $0.115500003/$0.319999992.

Recent News

chart

Pacific Software, Inc. (PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Pacific Software, Inc. (PFSF) is an emerging technology corporation positioned for investments, mergers and acquisitions of software technologies and platforms. The company is building “BoaPin,” a subscription-based e-commerce trading platform focused on cross border trade expansion with an international emphasis. The multi-faceted e-commerce platform is scheduled for launch in Q1 of 2019.

The Company is uniquely positioned to deliver a B2B and B2C intelligent e-commerce trade platform which will provide various solutions, data, applications and tools for subscribers, including IBM’s Hyperledger Blockchain “Backend as a Service” (BaaS) Infrastructure, multi-lingual communication, fintech, digital marketing, smart contracts, commodities search/match applications, customs clearance, taxation data, product advertising and logistics solutions.

Through smart contract technology for global supply chain management, BoaPin is designed to improve product traceability and deliver solutions to its subscribers for product certification, marketing, logistics, commodities search/match interface, trade finance, cross border payment solutions and customs clearance. Some of the tools available to execute these capabilities include cross border payments, blockchain solutions, smart contracts and multilingual access.

With these features at hand, the company is targeting several key industries where its online applications and solutions could have significant corporate impact in various forms, including: agriculture, fertilizers, chemicals, cosmetics, electronics, equipment, apparel and controlled substance management.

Business Model

Pacific Software initially will focus on Brazil and China for BoaPin. After paying a registration fee to utilize the online trade portal, subscribers to the platform will have access to a variety of tools and features that may enhance and increase revenue initiatives by showcasing their commodities and products for sale or trade.

Buyers of the commodities, products or services will pay a transaction fee only to the company which could materialize in the form of cash, cash equivalents, royalties or in-kind fees.

As the company executes its strategy, the online trade business is anticipated to generate significant revenue from subscribers obtained from regionally and federally organized Brazilian Trade Associations. The members wish to market their commodities or products, and the portal users or buyers materialize from China, Hong Kong and surrounding countries. As a result, this business model may be organized separately in the company’s wholly owned subsidiary, incorporated as HyperSoft Ventures, which could generate appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed Friday's trading session at $4.50, even for the day, on 50 volume. The stock's 52-week low/high is $2.00/$5.50.

Recent News

chart

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF)

The QualityStocks Daily Newsletter would like to spotlight Therma Bright, Inc. (OTC: THRBF).

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) is a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical industry. The company’s effective, non-invasive and pain-free skin care is based on proprietary technology which has received Class II medical device status from the U.S. Food and Drug Administration.

Therma Bright’s portfolio includes products, devices and treatments that have both cosmetic and medicinal or therapeutic benefits, such as for relief of pain, itch and inflammation resulting from more than 20,000 types of insect and marine life bites and stings, including bees, wasps, hornets, mosquitos, black flies and jellyfish.

The Company’s current focus is to market its products online through various social media networks, and to eventually re-establish relationships with major North American and Global retailers.

Products

The company currently has two products on the market and another in the research and development phase:

InterceptCS™ is a thermal therapy device for the treatment and prevention of cold sores caused by the herpes simplex Type 1 virus*. Symptoms typically include sores around the mouth and lips which InterceptCS™ treats by application of controlled topical heat with no risk of burning the skin. When used at the first sign of an oncoming cold sore application of InterceptCS™ can prevent symptoms from developing. Infrared energy and light from the device penetrate the skin killing cells infected with the virus.

InterceptCS™ is available without prescription and comprises a battery powered ergonomic hand-held unit and a disposable single-use treatment activator. Therma Bright has completed prototyping of multi-use activators for InterceptCS™. The company plans to bring to market 5, 10 or 20 multi-use activations at prices that will offer customers greater value than the current single-use activator.

The other Therma Bright product currently under development is TherOZap™, a next generation thermal therapy device powered by the company’s core technology, which is approved by the FDA as a Class II medical device for the relief of the symptoms of insect bites. Therma Bright is testing a new easier-to-use prototype of the device for effectiveness against Zika virus and other diseases carried by mosquitos. Once the technology proves effective, Therma Bright intends to seek regulatory approvals and extend the prototype enhancements to a new commercial version of TherOZap™.

Cannabis

Therma Bright is also conducting research and development on a unique thermal therapy device that would incorporate medical grade cannabis or cannabidiol (“CDB”) sourced from hemp as a cream or gel to provide relief of back, knee and other joint pain. In preparation, the company has incorporated a wholly owned subsidiary to hold any technology for use or application of cannabis. Once approvals are secured, the company plans to sell the device through licensed cannabis producers or retailers across Canada and in international markets where use of cannabis has been legalized. The company has initiated trademark and patent protection for its thermal therapy technology incorporating medical cannabis. Therma Bright has indicated it will seek an acquisition to help further development of this product.

Market Opportunity

A report by market intelligence firm Mordor Intelligence put the global cosmeceuticals market at a value of nearly US$47 billion in 2017 and projects it to be worth more than $80 billion by 2023, growing at a rate of almost 9.5 percent annually. Medical research estimates that somewhere between 20 percent and 40 percent of the population suffer occasional cold sore outbreaks. In Canada those figures would mean five to 10 million people, and in the U.S. some 40 million to 80 million, with recurring cold sores, representing a substantial potential market for Therma Bright.

Management

Rob Fia serves as Therma Bright chairman and CEO. Fia has extensive contacts in the investment community and the financial sector as well as knowledge of various Canadian stock exchange listing processes and requirements. His 18 years in the investment business has included equity research and advising promising early stage companies on corporate finance. Therma Bright CFO Victor Hugo is a senior financial analyst at Marrelli Support Services Inc., for which he provides CFO, accounting, regulatory compliance, and management advisory services to companies listed on the TSX, TSX Venture Exchange and other Canadian and US exchanges.

**Based on double blind placebo study, the InterceptCS™ is approved by Health Canada for the claim “For prevention of cold sores when used within 3 hours of the onset of the prodrome.” The InterceptCS™ is not approved by the United States FDA or any claim of clinical indication, clinical efficacy, and/or cure or prevention of disease.

Therma Bright, Inc. (OTC: THRBF), closed Friday's trading session at $0.022, even for the day, on 250 volume. The average volume for the last 3 months is 3 and the stock's 52-week low/high is $0.009899999/$0.028999999.

Recent News

chart

Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

Choom Holdings Inc. (OTC: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed Friday's trading session at $0.333, off by 0.44843%, on 168,044 volume with 74 trades. The average volume for the last 3 months is 284,800 and the stock's 52-week low/high is $0.284999996/$1.12999999.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.